Linde Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags\n\nLinde (<a>NASDAQ:LIN</a>) Second Quarter 2025 Results\n\nKey Financial Results\n\nRevenue: US$8.50b (up 2.8% from 2Q 2024).\n\nNet income: US$1.77b (up 6.2% from 2Q 2024).\n\nProfit margin: 21% (in line with 2Q 2024).\n\nEPS: US$3.75 (up from US$3.47 in 2Q 2024).\n\nLinde Revenues Beat Expectations, EPS Falls Short\n\nRevenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 1.5%.\n\nLooking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in the US.\n\nThe company's shares are down 2.9% from a week ago.\n\nRisk Analysis\n\nWe don't want to rain on the parade too much, but we did also find <a>2 warning signs for Linde</a> that you need to be mindful of.\n\nHave feedback on this article? Concerned about the content? <a>Get in touch</a> with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Linde Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Linde reported second-quarter 2025 revenue of $8.5 billion (up 2.8% from 2Q 2024) and net income of $1.77 billion (up 6.2% from 2Q 2024). Earnings per share (EPS) rose to $3.75 (up from $3.47 in 2Q 2024) but missed analyst estimates by 1.5%. Revenue exceeded estimates by 1.4%, while the company’s shares fell 2.9% from a week ago. Revenue growth is forecast to average 5.0% over the next three years, outpacing the 4.4% growth forecast for the U.S. Chemicals industry.